08:31 AM EDT, 10/08/2025 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said Wednesday that the European Patent Office has upheld all claims in one of its key patents related to its nasal epinephrine spray, covering formulations that include ingredients like Intravail.

The company said the patent is valid in over 30 European countries and protects the product through at least 2039.